Caidya®

Blog

Blog

Data Protection and Cross-Border Transfers — Ensuring GDPR Compliance in Multinational Trials

April 2026

Article 5 of our 8-part series "Regulatory Challenges for Chinese Biotech Expanding Trials to Europe"- This blog explains why GDPR compliance is essential for multinational clinical trials involving cross-border data transfers. It highlights key safeguards that protect patient privacy while supporting compliant, efficient trial execution.
Blog

Ethics Review and Localization: Managing Multinational Approvals Effectively

April 2026

Article 4 of our 8-part series "Regulatory Challenges for Chinese Biotech Expanding Trials to Europe"- this blog focuses on managing ethics review and localization under the EU Clinical Trials Regulation. It highlights key challenges and practical strategies to help Chinese biotech companies navigate national variations and streamline multinational trial approvals across Europe.
Blog

From Data to Compliance: Key Elements of IMPD and CTA Preparation

April 2026

Article 3 of our 8-part series: “Regulatory Challenges for Chinese Biotech Expanding Trials to Europe.” This article in our Regulatory Challenges for Chinese Biotech Expanding Trials to Europe series outlines the essential elements of a compliant IMPD and underscores the importance of seamless alignment with the broader CTA package.
Blog

Advancing Endometriosis Research: The Importance of Patient-Centered Clinical Trials

March 2026

March is Endometriosis Awareness Month, highlighting a condition that affects approximately 190 million women worldwide yet remains underdiagnosed and under-researched.
Blog

Bridging Regulatory Systems: From China’s IND to Europe’s CTA

March 2026

Article 2 of our 8-part series: “Regulatory Challenges for Chinese Biotech Expanding Trials to Europe.” Each article will cover a critical aspect of Europe’s regulatory landscape to help Chinese biotech sponsors expand smoothly and compliantly.
Blog

Webinar Recap: De-Risking Rare Kidney Disease Trials and Turning Biology into Clarity

February 2026

Rare kidney disease development has accelerated in recent years, yet many programs still struggle to produce clear, decisive outcomes.

Blog

Rethinking the Model: How Agile Players Can Rewrite the Future of Patient-Centered Research

December 2025

Biopharma, biotech, and pharma leaders know well the challenges we face: escalating costs, lengthening timelines, inefficiencies, and a persistent gap between the needs of patients and the realities of clinical trials.
Blog

Decentralized Clinical Trials: Challenges and Insights from the AICRO Workshop in Rome

December 2025

The discussions left me with a clear sense that DCTs are no longer optional innovations, they are essential to the future of clinical research.

Blog

Celebrating 20 Years of Dedication: A Conversation With Naim Salija

December 2025

Not many people can say they’ve grown alongside a company for two decades — through transformations, technology revolutions, and global expansion. But Naim Salija, Senior Director of End User Services at Caidya, can.
Blog

Navigating FDA Regulatory Processes as the Government Reopens

November 2025

With the passage of a new spending bill, federal agencies — including the U.S. Food and Drug Administration (FDA) — are resuming normal operations after the October – November 2025 shutdown. While critical FDA review work continued under carryover user fees, the freeze on new submissions and limited communications created operational gaps.
Blog

Understanding and Applying EU CTR: Navigating Successful Clinical Trial Submissions

November 2025

Blog 1 of our 8-part series: For biotech and pharmaceutical companies, especially those with no previous experience with the EU/EEA region, understanding this framework is essential to ensure smooth and regulatory compliant clinical trial submissions.
Blog

Regulatory Challenges for Chinese Biotech Expanding Trials to Europe

November 2025

Intro blog: To help guide sponsors through this process, our eight-part series, “Regulatory Challenges for Chinese Biotech Expanding Trials to Europe”, breaks down the most critical regulatory topics that impact clinical trial success under the EU CTR framework.
Blog

Emerging Immunotherapy Combinations and Novel Approaches for Oncology and Hematology: Keys to Designing and Operationalizing Your Trial

October 2025

The past decade has seen immunotherapy shift from a promising innovation to a core pillar of cancer treatment. What began with checkpoint inhibitors has now expanded into a crowded pipeline of biologics, antibody-drug conjugates, cell therapies, and precision medicine strategies.
Blog

World Mental Health Day 2025: The People Behind Clinical Research

October 2025

In clinical research, much of our focus centers on timelines, milestones, and deliverables, the measurable outcomes that define project success. But behind every protocol, every database lock, and every submission deadline is a person.
Blog

Recognizing Breast Cancer Symptoms: Clinical Considerations Across Oncology and Women’s Health

October 2025

Breast cancer is the most commonly diagnosed cancer in women globally, with more than 2.3 million new cases each year. While significant progress has been made in diagnosis and treatment, early detection remains one of the most powerful tools for improving patient outcomes.
Blog

Dermatology Imaging and Innovation: Raising the Quality Bar

October 2025

The session brought together industry experts to discuss the latest advances in dermatology clinical trial imaging, including the integration of photography and artificial intelligence (AI).
Blog

Navigating FDA Regulatory Challenges During a U.S. Government Shutdown

October 2025

As of October 1, 2025, the U.S. government has entered a partial shutdown because Congress failed to pass the appropriation bills required for fiscal year 2026.
Blog

Protecting Pediatric Patients: Advancing Drug Safety Through Pharmacovigilance

September 2025

In drug development and clinical practice, children are often misunderstood as merely requiring a scaled‑down version of adult doses.
Blog

Requesting FDA feedback early in development (in addition to Pre-IND Meeting)

September 2025

If you're in the early stages of product development and wondering what the FDA might think about your approach or if your product doesn’t fit neatly into existing categories, this meeting could give you clarity, confidence, and a stronger path forward.
Blog

Considerations in conducting Rare Disease studies: Lessons from our Boston Seminar

August 2025

During a recent dinner seminar in Boston, we shared deeply personal, practical, and strategic insights on what it truly takes to operationalize rare disease clinical trials. The event was filled with candid observations, compelling stories, and bold challenges to conventional thinking.
Blog

ASCO 2025: Key Takeaways for Clinical-Stage Biopharma Innovators

June 2025

At the 2025 ASCO Annual Meeting, key trends emerged in immunotherapy, antibody-drug conjugates, precision medicine, and clinical trial design.

Blog

The Caidya Values Recognition Awards 2025

June 2025

To honor our dedicated teams and individual team members, we recently held the Caidya Values Recognition Awards 2025. We invite you to learn about our teams and people who go above and beyond to exemplify our core values as they help our clients bring life-changing products to patients.
Blog

Our Culture of Caring: Demonstrating our Commitment to the Communities We Serve

May 2025

At Caidya, our commitment to patient-focused research extends into the communities we serve. Project Manager Natalie Negron recently participated in Lauren’s Run & Picnic, a community event supporting pediatric cancer research, and shared how experiences like this bring deeper meaning to our mission.
Blog

Boost Your Dermatology Studies: 5 Operational Essentials

April 2025

Dermatology studies demand careful planning and precise execution to ensure the reliability and validity of research outcomes.

Blog

Creating Your Blueprint: Strategic Planning for Early Phase Clinical Trials

March 2025

As the first stage of testing a new treatment in humans, the results from an early phase clinical trial provide critical data about safety and efficacy and help inform decision-making.
Blog

Strategies for Dose Selection in Oncology Drug Development: Optimus Project and Beyond

March 2025

In the world of cancer drug development, finding the right dose is a crucial step that can make a significant difference in how well a treatment works for patients.
Leading a new way

The latest from Caidya

Explore our news and updates as we deliver a superior customer experience.

Events

OCT Europe 2026

6th May 2026 to 7th May 2026
Hyatt Regency Barcelona Tower
View Event

Events

2026 CMAC Pharmacovigilance Annual Meeting

8th May 2026 to 9th May 2026
Suzhou International Expo Center, Suzhou, China
View Event

News

02/17/2026

Caidya Names Michael Clay COO to Drive Operational Excellence and Advance Multi-Regional Clinical Development

RALEIGH, N.C.; February 17, 2026 – Caidya, a leading global,...
Read more
Skip to toolbar